Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Summary

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: This phase II trial is studying vaccine therapy given after standard therapy to see how well it works in treating patients with stage III non-small cell lung cancer.

Timeline

Start

2000-08

Primary completion

—

Completion

2005-12

Publications

• Background Read EJ, Carter CS, Lee J, et al.: Clinical scale preparation of antigen-pulsed mature autologous dendritic cells for tumor-specific immunotherapy. [Abstract] ISHAGE 2001 Seventh Annual Symposium A-100, 2001.

Drugs

Indications